Teicoplanin therapy leading to a significant decrease in viral load in a patient with chronic hepatitis C.
作者信息
Maieron Andreas, Kerschner Heidrun
出版信息
J Antimicrob Chemother. 2012 Oct;67(10):2537-8. doi: 10.1093/jac/dks217. Epub 2012 Jun 11.
Abstract
摘要
相似文献
1
Teicoplanin therapy leading to a significant decrease in viral load in a patient with chronic hepatitis C.替考拉宁治疗使一名慢性丙型肝炎患者的病毒载量显著下降。
J Antimicrob Chemother. 2012 Oct;67(10):2537-8. doi: 10.1093/jac/dks217. Epub 2012 Jun 11.
2
Inhibition of hepatitis C virus replication by semi-synthetic derivatives of glycopeptide antibiotics.糖肽类抗生素半合成衍生物抑制丙型肝炎病毒复制。
J Antimicrob Chemother. 2011 Jun;66(6):1287-94. doi: 10.1093/jac/dkr104. Epub 2011 Mar 24.
3
[Subgenomic replications of hepatitis C virus (HCV): new possibilities for hepatitis C prophylaxis and treatment].[丙型肝炎病毒（HCV）的亚基因组复制：丙型肝炎预防和治疗的新可能性]
Gastroenterol Hepatol. 2001 Dec;24(10):506-10. doi: 10.1016/s0210-5705(01)70224-5.
4
Medicinal Chemistry of Hepatitis C Virus: Current and Future Perspective.丙型肝炎病毒的药物化学：现状与未来展望
Curr Top Med Chem. 2016;16(12):1350. doi: 10.2174/156802661612160303150629.
5
Will interferon-free regimens prevail?无干扰素方案会成为主流吗？
Gastroenterology. 2012 May;142(6):1351-5. doi: 10.1053/j.gastro.2011.12.062.
6
Priming of Antiviral CD8 T Cells without Effector Function by a Persistently Replicating Hepatitis C-Like Virus.持续复制的丙型肝炎样病毒对抗病毒 CD8 T 细胞的启动而无效应功能。
J Virol. 2020 May 4;94(10). doi: 10.1128/JVI.00035-20.
7
The suppressive effect that myriocin has on hepatitis C virus RNA replication is independent of inhibition of serine palmitoyl transferase.麦角硫因对丙型肝炎病毒RNA复制的抑制作用独立于对丝氨酸棕榈酰转移酶的抑制。
J Infect Dis. 2008 Oct 1;198(7):1091-3. doi: 10.1086/591463.
8
Continued value in understanding viral kinetic decline during interferon-free therapy for HCV.
Liver Int. 2015 Feb;35(2):295-6. doi: 10.1111/liv.12748.
9
Distinct Antiviral Potency of Sofosbuvir Against Hepatitis C and E Viruses.索磷布韦对丙型肝炎病毒和戊型肝炎病毒的不同抗病毒效力
Gastroenterology. 2016 Dec;151(6):1251-1253. doi: 10.1053/j.gastro.2016.09.061. Epub 2016 Nov 1.
10
Understanding hepatitis C viral dynamics with direct-acting antiviral agents due to the interplay between intracellular replication and cellular infection dynamics.了解直接作用抗病毒药物的丙型肝炎病毒动力学，因为细胞内复制和细胞感染动力学之间存在相互作用。
J Theor Biol. 2010 Dec 7;267(3):330-40. doi: 10.1016/j.jtbi.2010.08.036. Epub 2010 Sep 8.
引用本文的文献
1
Repositioning of Antibiotics in the Treatment of Viral Infections.抗生素在病毒感染治疗中的再定位。
Curr Microbiol. 2024 Oct 26;81(12):427. doi: 10.1007/s00284-024-03948-7.
2
Glycopeptides as Potential Interventions for COVID-19.糖肽类作为新冠病毒病的潜在干预措施
Biologics. 2020 Oct 13;14:107-114. doi: 10.2147/BTT.S262705. eCollection 2020.
3
COVID-19 Therapeutic Options Under Investigation.正在研究的COVID-19治疗方案。
Front Pharmacol. 2020 Aug 6;11:1196. doi: 10.3389/fphar.2020.01196. eCollection 2020.
4
Battling COVID-19: using old weapons for a new enemy.抗击新冠疫情：用旧武器应对新敌人。
Trop Dis Travel Med Vaccines. 2020 May 20;6:6. doi: 10.1186/s40794-020-00107-1. eCollection 2020.
5
A review on cell wall synthesis inhibitors with an emphasis on glycopeptide antibiotics.一篇关于细胞壁合成抑制剂的综述，重点是糖肽类抗生素。
Medchemcomm. 2017 Jan 26;8(3):516-533. doi: 10.1039/c6md00585c. eCollection 2017 Mar 1.
6
Fighting viruses with antibiotics: an overlooked path.用抗生素对抗病毒：一条被忽视的途径。
Int J Antimicrob Agents. 2016 Oct;48(4):349-52. doi: 10.1016/j.ijantimicag.2016.07.004. Epub 2016 Aug 5.
7
Glycopeptide Antibiotics Potently Inhibit Cathepsin L in the Late Endosome/Lysosome and Block the Entry of Ebola Virus, Middle East Respiratory Syndrome Coronavirus (MERS-CoV), and Severe Acute Respiratory Syndrome Coronavirus (SARS-CoV).糖肽类抗生素可有效抑制晚期内体/溶酶体中的组织蛋白酶L，并阻断埃博拉病毒、中东呼吸综合征冠状病毒（MERS-CoV）和严重急性呼吸综合征冠状病毒（SARS-CoV）的进入。
J Biol Chem. 2016 Apr 22;291(17):9218-32. doi: 10.1074/jbc.M116.716100. Epub 2016 Mar 7.
8
Teicoplanin inhibits Ebola pseudovirus infection in cell culture.替考拉宁在细胞培养中抑制埃博拉假病毒感染。
Antiviral Res. 2016 Jan;125:1-7. doi: 10.1016/j.antiviral.2015.11.003. Epub 2015 Nov 14.
9
Rational selection and engineering of exogenous principal sigma factor (σ(HrdB)) to increase teicoplanin production in an industrial strain of Actinoplanes teichomyceticus.理性选择和工程化外源性主要 σ 因子（σ（HrdB））以提高游动放线菌工业菌株的泰利霉素产量。
Microb Cell Fact. 2014 Jan 16;13:10. doi: 10.1186/1475-2859-13-10.
本文引用的文献
1
The dependence of viral RNA replication on co-opted host factors.病毒 RNA 复制对被劫持的宿主因子的依赖性。
Nat Rev Microbiol. 2011 Dec 19;10(2):137-49. doi: 10.1038/nrmicro2692.
2
Inhibition of hepatitis C virus replication by semi-synthetic derivatives of glycopeptide antibiotics.糖肽类抗生素半合成衍生物抑制丙型肝炎病毒复制。
J Antimicrob Chemother. 2011 Jun;66(6):1287-94. doi: 10.1093/jac/dkr104. Epub 2011 Mar 24.
3
Heterologous immunity between viruses.病毒之间的异源免疫。
Immunol Rev. 2010 May;235(1):244-66. doi: 10.1111/j.0105-2896.2010.00897.x.
4
Polycyclic peptide and glycopeptide antibiotics and their derivatives as inhibitors of HIV entry.多环肽和糖肽类抗生素及其衍生物作为HIV进入抑制剂
Antiviral Res. 2006 Sep;71(2-3):227-36. doi: 10.1016/j.antiviral.2006.04.008. Epub 2006 May 6.
5
Inhibition of feline (FIPV) and human (SARS) coronavirus by semisynthetic derivatives of glycopeptide antibiotics.糖肽类抗生素半合成衍生物对猫（猫传染性腹膜炎病毒）和人（严重急性呼吸综合征）冠状病毒的抑制作用
Antiviral Res. 2006 Oct;72(1):20-33. doi: 10.1016/j.antiviral.2006.03.005. Epub 2006 Apr 6.
6
Pharmacodynamic evaluation of the intracellular activities of antibiotics against Staphylococcus aureus in a model of THP-1 macrophages.在THP-1巨噬细胞模型中对抗生素针对金黄色葡萄球菌的细胞内活性进行药效学评估。
Antimicrob Agents Chemother. 2006 Mar;50(3):841-51. doi: 10.1128/AAC.50.3.841-851.2006.
7
Cross-reactivity between hepatitis C virus and Influenza A virus determinant-specific cytotoxic T cells.丙型肝炎病毒与甲型流感病毒决定簇特异性细胞毒性T细胞之间的交叉反应性。
J Virol. 2001 Dec;75(23):11392-400. doi: 10.1128/JVI.75.23.11392-11400.2001.
Zotero 插件